Energetic cost of breathing, body composition, and pulmonary function in horses with recurrent airway obstruction

Journal of Applied Physiology

Volumn 97, Issue 1, 2004, Pages 91-97

  Mazan, Melissa R ^a   Deveney, Edward F ^b   DeWitt, Shane ^a   Bedenice, Daniela ^a   Hoffman, Andrew ^a  

^a TUFTS UNIVERSITY   (United States)

^b BRIDGEWATER STATE UNIVERSITY   (United States)

Author keywords

Indirect calorimetry; Ipratropium bromide; Naturally occurring disease; Oxygen consumption; Resting energy expenditure

Indexed keywords

BRONCHODILATING AGENT; CARBON DIOXIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; OXYGEN; XYLAZINE;

AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ARTICLE; B SCAN; BALLOON; BODY COMPOSITION; BODY FAT; BREATHING; BREATHING RATE; BRONCHODILATATION; CACHEXIA; CALCULATION; CALORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENERGY EXPENDITURE; HORSE DISEASE; LUNG COMPLIANCE; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG RESISTANCE; NONHUMAN; OXYGEN CONSUMPTION; PNEUMOTACHYGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY AIRFLOW; REST; SCORING SYSTEM; SEDATION; THORAX PRESSURE; TIDAL VOLUME;

ADRENERGIC ALPHA-AGONISTS; AEROSOLS; AIRWAY OBSTRUCTION; ANIMALS; BODY COMPOSITION; BRONCHODILATOR AGENTS; CALORIMETRY, INDIRECT; CARBON DIOXIDE; CHRONIC DISEASE; ELASTICITY; ENERGY METABOLISM; FEMALE; HORSE DISEASES; HORSES; HYPNOTICS AND SEDATIVES; LUNG; MALE; OXYGEN; PHYSICAL CONDITIONING, ANIMAL; RECURRENCE; RESPIRATORY FUNCTION TESTS; RESPIRATORY MECHANICS; XYLAZINE;

EID: 3042515917     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00629.2003     Document Type: Article

References (57)

1. American Association for Respiratory Care. AARC clinical practice guideline. Metabolic measurement using indirect calorimetry during mechanical ventilation. Respir Care 39: 1170-1175, 1994.
2. Art T, Duvivier DH, Votion D, Anciaux N, Vandenput S, Bayly WM, and Lekeux P. Does an acute COPD crisis modify the cardiorespiratory and ventilatory adjustments to exercise in horses? J Appl Physiol 84: 845-852, 1998.
3. Benedict F. Vital Energetics: A Study in Comparative Basal Metabolism. Washington, DC: Carnegie Institution of Washington, 1938.
4. Broadstone RV, Gray PR, Robinson NE, and Derksen FJ. Effects of xylazine on airway function in ponies with recurrent airway obstruction. Am J Vet Res 53: 1813-1817, 1992.
5. Broadstone RV, Scott JS, Derksen FJ, and Robinson NE. Effects of atropine in ponies with recurrent airway obstruction. J Appl Physiol 65: 2720-2725, 1988.
6. Burdet L, de Muralt B, Schutz Y, and Fitting JW. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease. Thorax 52: 130-135, 1997.
7. Bureau F, Delhalle S, Bonizzi G, Fievez L, Dogne S, Kirschvink N, Vanderplasschen A, Merville MP, Bours V, and Lekeux P. Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. J Immunol 165: 5822-5830, 2000.
8. Bye PT, Farkas GA, and Roussos C. Respiratory factors limiting exercise. Annu Rev Physiol 45: 439-451, 1983.
9. Cosio Piqueras MG and Cosio MG. Disease of the airways in chronic obstructive pulmonary disease. Eur Respir J Suppl 34: 41s-49s, 2001.
10. De Godoy I, Donahoe M, Calhoun WJ, Mancino J, and Rogers RM. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 153: 633-637, 1996.
11. Di Francia M, Barbier D, Mege JL, and Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150: 1453-1455, 1994.
12. Donahoe M, Rogers RM, Wilson DO, and Pennock BE. Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 140: 385-391, 1989.
13. Duvivier DH, Bayly WM, Votion D, Vandenput S, Art T, Farnir F, and Lekeux P. Effects of inhaled dry powder ipratropium bromide on recovery from exercise of horses with COPD. Equine Vet J 31: 20-24, 1999.
14. Duvivier DH, Votion D, Vandenput S, Art T, and Lekeux P. Airway response of horses with COPD to dry powder inhalation of ipratropium bromide. Vet J 154: 149-153, 1997.
15. 2 measuring systems. J Appl Physiol 51: 772-776, 1981.
16. Franchini M, Gilli U, Akens MK, Fellenberg RV, and Bracher V. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Vet Immunol Immunopathol 66: 53-65, 1998.
17. Giguere S, Viel L, Lee E, MacKay RJ, Hernandez J, and Franchini M. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Vet Immunol Immunopathol 85: 147-158, 2002.
18. Henneke D, Potter G, Kreider J, and Yeates B. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 15: 371-372, 1983.
19. Jones JH, Longworth KE, Lindholm A, Conley K, Karas RH, Kayar SR, and Taylor CR. Oxygen transport during exercise in large mammals. I. Adaptive variation in oxygen demand. J Appl Physiol 67: 862-870, 1989.
20. Kane R, Fisher M, Parrett D, and Lawrence L. Estimating fatness in horses. Proc 10th Equine Nutr Physiol Symp, Ft Collins, CO, 1987, p. 127-131.
21. Kearns CF, McKeever KH, Malinowski K, Struck MB, and Abe T. Chronic administration of therapeutic levels of clenbuterol acts as a repartitioning agent. J Appl Physiol 91: 2064-2070, 2001.
22. Korducki M, Forster H, Lowry T, and Forster M. Effect of hypoxia on metabolic rate in awake ponies. J Appl Physiol 76: 2380-2385, 1994.
23. Koterba AM, Kosch PC, Beech J, and Whitlock T. Breathing strategy of the adult horse (Equus caballus) at rest. J Appl Physiol 64: 337-346, 1988.
24. 2 transport in the horse during rest and exercise. Adv Exp Med Biol 227: 333-336.
25. Lavoie JP, Pascoe JR, and Kurpershoek CJ. Effect of head and neck position on respiratory mechanics in horses sedated with xylazine. Am J Vet Res 53: 1652-1657, 1992.
26. Lavoie JP, Pascoe JR, and Kurpershoek CJ. Effects of xylazine an ventilation in horses. Am J Vet Res 53: 916-920, 1992.
27. Leith D and Gillespie JR. Respiratory mechanics of normal horses and one with chronic obstructive lung disease (Abstract). Fed Proc 30: 556, 1971.
28. Lowell F. Observations on heaves. An asthma-like syndrome in the horse. Allergy Proc 11: 149-150, 1964.
29. 2 cost of ventilation contributes to tissue wasting in COPD. Chest 115: 708-713, 1999.
30. Mansell PI and Macdonald IA. Reappraisal of the Weir equation for calculation of metabolic rate. Am J Physiol Regul Integr Comp Physiol 258: R1347-R1354, 1990.
31. Martin J, Powell E, Shore S, Emrich J, and Engel LA. The role of respiratory muscles in the hyperinflation of bronchial asthma. Am Rev Respir Dis 121: 441-447, 1980.
32. Mazan MR, Hoffman AM, Kuehn H, and Deveney EF. Effect of aerosolized albuterol sulfate on resting energy expenditure determined by use of open-flow indirect calorimetry in horses with recurrent airway obstruction. Am J Vet Res 64: 235-242, 2003.
33. Mazan MR, Hoffman AM, and Manjerovic N. Comparison of forced oscillation with the conventional method for histamine bronchoprovocation testing in horses. Am J Vet Res 60: 174-180, 1999.
34. McGorum BC, Ellison J, and Cullen RT. Total and respirable airborne dust endotoxin concentrations in three equine management systems. Equine Vet J 30: 430-434, 1998.
35. Mosier K, Renvall MJ, Ramsdell JW, and Spindler AA. The effects of theophylline on metabolic rate in chronic obstructive lung disease patients. J Am Coll Nutr 15: 403-407, 1996.
36. Muylle E and Oyaert W. Lung function tests in obstructive pulmonary disease in horses. Equine Vet J 5: 37-44, 1973.
37. Newth CJ, Amsler B, Richardson BP, and Hammer J. The effects of bronchodilators on spontaneous ventilation and oxygen consumption in rhesus monkeys. Pediatr Res 42: 157-162, 1997.
38. Ott E. National Research Council: Nutrient Requirements of Horses. Washington, DC: National Academy Press, 1989.
39. Pearson EG and Riebold TW. Comparison of bronchodilators in alleviating clinical signs in horses with chronic obstructive pulmonary disease. J Am Vet Med Assoc 194: 1287-1291, 1989.
40. Polito A, Fabbri A, Ferro-Luzzi A, Cuzzolaro M, Censi L, Ciarapica D, Fabbrini E, and Giannini D. Basal metabolic rate in anorexia nervosa: relation to body composition and leptin concentrations. Am J Clin Nutr 71: 1495-1502, 2000.
41. Robinson NE. International Workshop on Equine Chronic Airway Disease. Michigan State University 16-18 June 2000. Equine Vet J 33: 5-19, 2001.
42. Robinson NE, Derksen FJ, Berney C, and Goossens L. The airway response of horses with recurrent airway obstruction (heaves) to aerosol administration of ipratropium bromide. Equine Vet J 25: 299-303, 1993.
43. Robinson NE, Derksen FJ, Olszewski MA, and Buecbner-Maxwell VA. The pathogenesis of chronic obstructive pulmonary disease of horses. Br Vet J 152: 283-306, 1996.
44. Robinson NE, Olszewski MA, Boehler D, Berney C, Hakala J, Matson C, and Derksen FJ. Relationship between clinical signs and lung function in horses with recurrent airway obstruction (heaves) during a bronchodilator trial. Equine Vet J 32: 393-400, 2000.
45. Sasse HH. [Pulmonary function in the horse]. Tierarztl Prax 1: 49-59, 1973.
46. Schols AM, Fredrix EW, Soeters PB, Westerterp KR, and Wouters EF. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 54: 983-987, 1991.
47. Schols AM, Slangen J, Volovics L, and Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1791-1797, 1998.
48. Schulz C, Wolf K, Harth M, Kratzel K, Kunz-Schughart L, and Pfeifer M. Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers, and never-smokers. Respiration 70: 254-261, 2003.
49. Sergi G, Coin A, Bussolotto M, Beninca P, Tomasi G, Pisent C, Peruzza S, Inelmen EM, and Enzi G. Influence of fat-free mass and functional status on resting energy expenditure in underweight elders. J Gerontol A Biol Sci Med Sci 57: M302-M307, 2002.
50. Simonson D and DeFronzo R. Indirect calorimetry: methodological and interpretative problems. Am J Physiol Endocrinol Metab 258: E399-E412, 1990.
51. Takabatake N, Nakamura H, Abe S, Hino T, Saito H, Yuki H, Kato S, and Tomoike H. Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159: 1215-1219, 1999.
52. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, and Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 153: 1802-1811, 1996.
53. Vandenput S, Istasse L, Nicks B, and Lekeux P, Airborne dust and aeroallergen concentrations in different sources of feed and bedding for horses. Vet Q 19: 154-158, 1997.
54. Vaughan L, Zurlo F, and Ravussin E. Aging and energy expenditure. Am J Clin Nutr 53: 821-825, 1991.
55. Votion D, Ghafir Y, Vandenput S, Duvivier DH, Art T, and Lekeux P. Analysis of scintigraphical lung images before and after treatment of horses suffering from chronic pulmonary disease. Vet Rec 144: 232-236, 1999.
56. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. 1949. Nutrition 6: 213-221, 1990.
57. Woods PS, Robinson NE, Swanson MC, Reed CE, Broadstone RV, and Derksen FJ. Airborne dust and aeroallergen concentration in a horse stable under two different management systems. Equine Vet J 25: 208-213, 1993.